De Paepe et al., have proposed that SLC5A3 is a pathological hallmark that is upregulated in sporadic inclusion body myositis (IBM) tissues, which could be linked to the degenerative changes and inflammation of the disease [9]. This evidence concerns the gene SLC5A3 and inclusion body myositis.